Stroke
Showing NaN - NaN of 39
Endovascular Intervention for STroke Existing Disability
Not yet recruiting
- Stroke
- +2 more
- Endovascular Stroke Treatment
- Medical Management
-
Phoenix, Arizona
- +11 more
Jun 20, 2023
Stroke Trial in Worldwide (Sentinel® Cerebral Protection System)
Completed
- Stroke
- Sentinel® Cerebral Protection System
-
Tucson, Arizona
- +56 more
Jan 17, 2023
REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage
Enrolling by invitation
- Intra Cerebral Hemorrhage
- +11 more
-
Birmingham, Alabama
- +25 more
Jan 19, 2023
Cardiovascular Disease, Myocardial Infarction, Stroke Trial (Evolocumab, Routine Lipid Management)
Recruiting
- Cardiovascular Disease
- +3 more
- Evolocumab
- Routine Lipid Management
-
Fairhope, Alabama
- +14 more
Dec 21, 2022
Stroke, Patent Foramen Ovale Trial in Canada, United States (Investigational PFO Closure Device, Standard of Care PFO Closure
Enrolling by invitation
- Stroke
- Patent Foramen Ovale
- Investigational PFO Closure Device
- Standard of Care PFO Closure Device
-
Stanford, California
- +11 more
Dec 5, 2022
Atrial Fibrillation, Stroke Trial in United States (CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial
Enrolling by invitation
- Atrial Fibrillation
- Stroke
- CLAAS
- WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
-
Birmingham, Alabama
- +5 more
Aug 16, 2022
Peri-device Leakage Closure After LAAO
Completed
- Atrial Fibrillation
- +3 more
- Peri-device leakage closure after left atrial appendage occlusion
-
Phoenix, Arizona
- +15 more
Jul 20, 2022
Stroke Prevention in Young Adults With Sickle Cell Anemia
Active, not recruiting
- Sickle Cell Disease
- +5 more
- Hydroxyurea therapy per standard care
-
Nashville, Tennessee
- +1 more
Jul 13, 2022
Stroke Trial in Worldwide (Amulet Left Atrial Appendage Occluder, WATCHMAN Left Atrial Appendage Closure)
Active, not recruiting
- Stroke
- Amulet Left Atrial Appendage Occluder
- WATCHMAN Left Atrial Appendage Closure
-
Huntsville, Alabama
- +114 more
Jul 8, 2022
Stroke, PFO - Patent Foramen Ovale Trial in United States (PFO closure with GORE® CARDIOFORM Septal Occluder)
Recruiting
- Stroke
- PFO - Patent Foramen Ovale
- PFO closure with GORE® CARDIOFORM Septal Occluder
-
La Jolla, California
- +38 more
Jun 6, 2022
Sickle Cell Disease, Stroke, Neurologic Manifestations Trial in Nashville, Kano (This study does not entail offering any
Active, not recruiting
- Sickle Cell Disease
- +5 more
- This study does not entail offering any intervention; all data collected will be based on standard of care.
-
Nashville, Tennessee
- +2 more
Apr 14, 2022
Stroke, Hypertension Trial in Nashville (Technological Facilitator, Standard of Care)
Withdrawn
- Stroke
- Hypertension
- Technological Facilitator
- Standard of Care
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 4, 2022
Thromboembolism, Hemolysis, Stroke Trial in United States (Lavare On, Lavare Off)
Terminated
- Thromboembolism
- +2 more
- Lavare On
- Lavare Off
-
Birmingham, Alabama
- +3 more
Jan 13, 2022
Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )
Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)
Completed
- Stroke
- Secondary Prevention
- optional ASA as comedication
- +5 more
-
Phoenix, Arizona
- +568 more
Aug 13, 2019
Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (Botulinum Toxin Type A)
Completed
- Pediatrics
- +3 more
- Botulinum Toxin Type A
-
Pasadena, California
- +47 more
Jul 29, 2019
Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)
Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban
Completed
- Stroke
- +2 more
- warfarin tablets
- +4 more
-
Birmingham, Alabama
- +1015 more
Feb 8, 2019
Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)
Terminated
- Stroke
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Tucson, Arizona
- +453 more
Dec 20, 2018
Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (botulinum toxin Type A, Normal Saline (Placebo))
Completed
- Pediatrics
- +3 more
- botulinum toxin Type A
- Normal Saline (Placebo)
-
Pasadena, California
- +44 more
Jul 16, 2018
Atrial Fibrillation, Stroke Trial in United States (WATCHMAN Device, Warfarin)
Completed
- Atrial Fibrillation
- Stroke
- WATCHMAN Device
- Warfarin
-
Gilbert, Arizona
- +40 more
Jul 25, 2018
Stroke Trial in Canada, United States (Tissue plasminogen activator (Activase®))
Terminated
- Stroke
- Tissue plasminogen activator (Activase®)
-
Palo Alto, California
- +14 more
Apr 26, 2018
Impact of Neuromonitoring During Cardiac Procedures
Completed
- Delirium
- +2 more
-
Nashville, TennesseeVanderbilt University School of Medicine
Mar 13, 2018
Hemodynamic Compensation in Patients With Intracranial Stenosis
Completed
- Stroke
- Intracranial Stenosis
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 23, 2018